INOVIO PHARMACEUTICALS INC's ticker is and the CUSIP is 45773HAB8. A total of 17 filers reported holding INOVIO PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 1.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $6,049,225 | -1.2% | 6,500,000 | 0.0% | 0.01% | 0.0% |
Q2 2023 | $6,124,389 | +20.0% | 6,500,000 | 0.0% | 0.01% | +20.0% |
Q1 2023 | $5,104,121 | -12.1% | 6,500,000 | 0.0% | 0.01% | -16.7% |
Q4 2022 | $5,808,616 | +0.8% | 6,500,000 | 0.0% | 0.01% | -14.3% |
Q3 2022 | $5,764,000 | +26.0% | 6,500,000 | +30.0% | 0.01% | +40.0% |
Q2 2022 | $4,575,000 | -20.1% | 5,000,000 | 0.0% | 0.01% | 0.0% |
Q1 2022 | $5,726,000 | -3.4% | 5,000,000 | 0.0% | 0.01% | 0.0% |
Q4 2021 | $5,925,000 | -14.3% | 5,000,000 | 0.0% | 0.01% | -16.7% |
Q3 2021 | $6,912,000 | -21.1% | 5,000,000 | 0.0% | 0.01% | -25.0% |
Q2 2021 | $8,758,000 | -0.3% | 5,000,000 | 0.0% | 0.01% | 0.0% |
Q1 2021 | $8,784,000 | +6.1% | 5,000,000 | 0.0% | 0.01% | +14.3% |
Q4 2020 | $8,277,000 | -22.7% | 5,000,000 | 0.0% | 0.01% | -36.4% |
Q3 2020 | $10,709,000 | -57.0% | 5,000,000 | 0.0% | 0.01% | -63.3% |
Q2 2020 | $24,921,000 | +235.1% | 5,000,000 | 0.0% | 0.03% | +150.0% |
Q1 2020 | $7,437,000 | – | 5,000,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CVI Holdings, LLC | 2,000,000 | $2,984,000 | 10.48% |
Context Capital Management, LLC | 7,750,000 | $11,050,000 | 6.27% |
HIGHBRIDGE CAPITAL MANAGEMENT LLC | 4,750,000 | $9,690,000 | 1.04% |
TFG Asset Management GP Ltd | 1,500,000 | $2,230,000 | 0.39% |
DeepCurrents Investment Group LLC | 4,000,000 | $5,947,000 | 0.29% |
AQR Arbitrage LLC | 5,000,000 | $7,484,000 | 0.25% |
PALISADE CAPITAL MANAGEMENT, LP | 3,000,000 | $4,427,000 | 0.16% |
Soros Fund Management | 2,000,000 | $2,963,000 | 0.15% |
CSS LLC/IL | 1,000,000 | $1,470,000 | 0.12% |
Verition Fund Management LLC | 1,873,000 | $2,804,000 | 0.11% |